Raymond James Downgrades CME Group to Market Perform

Raymond James analyst Patrick O'Shaughnessy downgrades CME Group (NASDAQ:CME) from Outperform to Market Perform.

Raymond James analyst Patrick O’Shaughnessy downgrades CME Group (NASDAQ:CME) from Outperform to Market Perform.

Total
0
Shares
Related Posts
Read More

TransAct Technologies, Applied Blockchain And This Penny Stock Insiders Are Aggressively Buying

The Dow Jones jumped by more than 400 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AHNR